How Targeted Lifestyle Adjustments Can Significantly Lower Dementia Risk

According to findings presented at the Alzheimer's Association International Conference in London this August and now published in The Lancet, the capacity we hold to shape our cognitive aging is larger than the popular imagination tends to admit.

The trial — known as LatAm-FINGERS — followed older adults at risk of cognitive decline through a structured, multi-domain intervention that wove together physical activity, nutrition, medical monitoring, cognitive training, and social engagement. Participants in the intervention group improved their overall cognitive performance by up to 55% compared with peers who received only general health guidance, the study reports.

Built on a Nordic foundation

LatAm-FINGERS is the first multicenter randomized trial of its kind conducted in Latin America, but its design descends directly from Finland's original FINGER study. Published in The Lancet in 2015, that earlier trial tracked adults aged 60 to 77 over two years; the structured intervention group gained roughly 25% in overall cognitive performance compared with a control receiving standard advice. The result repositioned dementia prevention from aspiration to evidence.

A decade later, the U.S. POINTER trial, published in JAMA in 2025, examined more than 2,100 adults aged 60 to 79 at high risk of decline. The signal traveled with the participants: across continents and cultures, careful attention to the modifiable dimensions of daily life translated into measurable cognitive benefit.

The architecture of what we can reach

The Lancet's own commission, in its 2024 update, identified 14 modifiable risk factors that accumulate across a lifetime. Some arrive in childhood — illiteracy, limited educational access — while others emerge later: hearing loss, hypertension, diabetes, physical inactivity, reduced visual acuity. Together they constitute a portrait of how everyday conditions quietly shape the trajectory of cognition long before any formal diagnosis appears.

For us, the lesson is neither fatalism nor triumphalism. It is the recognition that the slow maintenance of body and social connection constitutes a genuine instrument against decline — accessible, if we choose to wield it. A 2022 meta-analysis of 31 studies across Latin America placed dementia prevalence at roughly 9% among adults aged 65 and older, one of the highest figures reported worldwide; that reality sharpens rather than contradicts the argument, because so much of the burden rests on factors we can influence.

Where we go from here

We will be watching for the full peer-reviewed LatAm-FINGERS publication and for any early moves by health systems to translate multi-domain prevention into routine, scalable practice. The conversation in 2026 is shifting from whether lifestyle change matters to how quickly the clinical world can absorb what the trials keep confirming.

In the meantime, the work belongs to us. The choices we make about movement, nutrition, sleep, social connection, and consistent medical follow-through remain the most practical instruments available — and the discipline to examine what is offered, to study the terms before committing, extends well beyond the clinic. Whether we are evaluating a new exercise regimen or scrutinizing the mechanics behind a concentrated liquidity arrangement, deliberation remains our most reliable safeguard against regret.